A5004186366- Cancer, Hypoxia, and Metabolism
- Forensic Toxicology and Drug Analysis
- Cannabis and Cannabinoid Research
- Alcohol Consumption and Health Effects
- Neuroendocrine Tumor Research Advances
- Psychedelics and Drug Studies
- Biochemical Acid Research Studies
- Pancreatic and Hepatic Oncology Research
- Medical History and Innovations
- Pleural and Pulmonary Diseases
- Esophageal and GI Pathology
- Cardiac and Coronary Surgery Techniques
- Complement system in diseases
- Hemoglobin structure and function
- Cancer-related Molecular Pathways
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Neuroblastoma Research and Treatments
- Hemodynamic Monitoring and Therapy
- History of Medical Practice
- DNA Repair Mechanisms
- Mitochondrial Function and Pathology
- Dysphagia Assessment and Management
- Trauma Management and Diagnosis
- Folate and B Vitamins Research
- Biochemical and Molecular Research
University of Bern
2023-2025
Universitat de Barcelona
1998
Wayne State University
1998
The Ohio State University
1995-1998
Case Western Reserve University
1988-1991
University Hospitals of Cleveland
1991
United States Department of Veterans Affairs
1989
Hexahydrocannabinol (HHC) is a cannabinoid that has been known since 1940 but only recently found its way into recreational use as psychoactive drug. HHC used legal alternative to tetrahydrocannabinol (THC) in many countries, first countries already placed it under their narcotic substances law. Our aim was evaluate reliable analytical method for the proof of consumption by LC-MS/MS and GC-MS. We identified two epimers metabolites after volunteers (inhalation vaporizer oral intake)....
Abstract After the Swiss ban of hexahydrocannabinol (HHC) in March 2023, other semisynthetic dibenzopyran cannabinoids emerged on gray market. Hexahydrocannabiphorol (HHCP) was most prominent them due to its potent cannabimimetic effects, as anecdotal reports from recreational users suggest. In October a class wide introduced Switzerland prevent new similar substances entering drug Various vendors online shops claim that HHCP is made CBD, even though they possess different alkyl chain...
ABSTRACT Hexahydrocannabiphorol (HHCP) is an emerging semisynthetic cannabinoid, which has been known since 1942 from research of tetrahydrocannabinol (THC) analogs and homologs. After the ban hexahydrocannabinol (HHC) in many European Countries HHCP emerged as a replacement among other similar compounds. First countries already placed under their narcotic substance law. The aim this was to identify human Phase I II metabolites urine after oral consumption. Enzymatic immunoassays samples...
Δ9-Tetrahydrocannabiphorol (Δ9-THCP, THCP) a psychoactive cannabinoid recently found in Cannabis sativa L., is widely used as legal marijuana substitute. THCP encountered sprayed Cannabis, edibles, and vape liquids. The distributors of such products claim that the use originates from natural source. status this substance varies country to country. similar cannabinoids with dibenzoyprane structure have been banned Switzerland since October 2023. A liquid, which contains 90% 10% terpenes...
HAMPTON, W. W.; TOWNSEND, M. C.; SCHIRMER, J.; HAYORON, D. M.; FRY, L. E. Author Information